ArticleInternational journal of applied & basic medical research
Baseline Assessment of Antimicrobial Use and Stewardship Gaps in a Tertiary Care Hospital in South India: A Point Prevalence Audit.
Article in International journal of applied & basic medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance is a major global public health concern, with a disproportionate burden in low- and middle-income countries. In hospital settings, inappropriate antimicrobial use, particularly excessive empirical and broad-spectrum prescribing, remains a key driver of resistance. Reliable baseline data on prescribing practices are essential for guiding antimicrobial stewardship interventions. Point prevalence surveys offer a standardized, resource-efficient method for assessing antimicrobial use. Yet, data from tertiary care hospitals in South India, particularly across both adult and pediatric services, remain limited. Aim: To assess the point prevalence of antimicrobial prescribing and identify key stewardship gaps across adult and pediatric inpatient services in a tertiary care teaching hospital in South India. Materials and Methods: A cross-sectional observational point prevalence survey was conducted in selected medicine and pediatric wards and intensive care units (ICUs). All eligible inpatients present on the survey days were included, excluding day-care admissions. The data were collected using a predesigned questionnaire adapted from the National Centre for Disease Control framework and were analyzed descriptively. Results: A total of 348 patients were surveyed, including 300 adults and 48 pediatric patients. Antimicrobial use varied substantially between wards and ICUs. In adult medicine wards, 29.5% of patients received antimicrobials, increasing to 75% in the medical ICU. Ceftriaxone was the most frequently prescribed agent in wards, while piperacillin-tazobactam predominated in the ICU. Pediatric antimicrobial use was 38.1% in wards and 83.3% in the pediatric ICU, with ampicillin being the most commonly prescribed agent. Empirical therapy predominated across all clinical settings. Culture-guided treatment was documented in only 6 of 115 patients (5.2%) receiving antimicrobials. Conclusion: This point prevalence survey-based audit provides baseline data on antimicrobial prescribing and identifies important stewardship gaps, including high empirical use and limited culture-guided therapy. Point prevalence survey methodology represents a feasible approach for informing antimicrobial stewardship strategies in resource-constrained tertiary care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.